Status:
COMPLETED
Desensitization for Highly Sensitized Recipients of Pancreas Transplantation
Lead Sponsor:
Northwestern University
Conditions:
Type 1 Diabetes
Rejection of Pancreas Transplant
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study for patients with type 1 diabetes, whom are already scheduled to have desensitization treatment to help increase the chance of receiving a pancreas transplant.The study ...
Detailed Description
Please note that this study is observational. The treatment of each patient will be at the discretion of the care physician. The study investigators will ONLY be performing data collection and analysi...
Eligibility Criteria
Inclusion
- Pancreas transplant recipients with elevated panel reactive antibody levels of \>50% and who have received desensitization treatment and subsequently receive their transplantation at Northwestern Memorial Hospital (NMH).
Exclusion
- No Exclusion criteria exist.
Key Trial Info
Start Date :
December 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00867386
Start Date
December 1 2006
End Date
October 1 2013
Last Update
March 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611